semaglutide compounding lawsuit news 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Off-Label Semaglutide Linked to Deaths,

If this story sounds familiar, its because the OFA also filed a lawsuit against the FDA when tirzepatide was removed from the federal drug shortage list in 2024

Tirzepatide microdose protocol: Starting at 0.5 mg weekly, holding for 4 to 6 weeks, with similar marker-based reassessment

It is a custom-made medication using the same active ingredients in Zepbound and Mounjaro and combined with B12 and glycine

Do GLP-1 medications have side effects

Patients must also take a trial of phentermine, an older drug chemically related to amphetamines and still widely used for weight loss, before they can be approved for GLP-1s